Insiders · HCWB

Peter Rhode

Officer at HCW Biologics Inc. (HCWB)

Peter Rhode has filed 4 insider reports with the SEC since September 2021, as officer at HCW Biologics Inc. (HCWB). The latest filing, on December 11, 2023, reports exercise or conversion of a derivative at HCW Biologics Inc. (HCWB).

Filings
4
Companies
1
Bought on market
None
Sold on market
None

Companies where Peter Rhode is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
HCW Biologics Inc. logo
HCWB
HCW Biologics Inc.
Officer77,500$0.7731Dec 11, 2023

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.

Every filing

Compare Peter Rhode with

Other insiders at the same companies

Questions about Peter Rhode

What is Peter Rhode's role at HCW Biologics Inc.?
Peter Rhode reports to the SEC as officer at HCW Biologics Inc. (HCWB), according to the latest filing on December 11, 2023.
How many shares does Peter Rhode own?
After the latest filing that states it, Peter Rhode directly owned 77,500 shares of HCW Biologics Inc. (HCWB). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has Peter Rhode bought or sold stock recently?
No open-market purchases or sales by Peter Rhode are on file. The filings report exercise or conversion of a derivative and grant or award.
How do I get alerts when Peter Rhode files?
Follow Peter Rhode on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by Peter Rhode (SEC CIK 0001866276). Totals count each trade once, skipping amendments whose original is on file, from Sep 10, 2021 on. View on SEC EDGAR